Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jordan Phillipps"'
Autor:
Favour A. Akinjiyan, George Nassief, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Farah Abdulla, Alice Y. Zhou, George Souroullas, Kevin B. Kim, Ari Vanderwalde, Soo J. Park, George Ansstas
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract ARID genes encode subunits of SWI/SNF chromatin remodeling complexes and are frequently mutated in human cancers. We investigated the correlation between ARID mutations, molecular features, and clinical outcomes in melanoma patients. Cutaneo
Externí odkaz:
https://doaj.org/article/12330a2b365b4ae9b93fc739ef7b1daa
Autor:
Renee Morecroft, Jordan Phillipps, Alice Zhou, Omar Butt, Karam Khaddour, Tanner Johanns, George Ansstas
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Immunotherapy is the first-line option for treating advanced cutaneous squamous cell carcinoma (cSCC). However, up to half of patients experience no benefit and treatment resistance, warranting newer therapeutic approaches. Combinatory approaches, in
Externí odkaz:
https://doaj.org/article/f2b84d8281f7481ab6a940c93f2daab0
Autor:
Remi K. Hamel, MD, Jordan Phillipps, BS, Tariq Nisar, MPH, Elizabeth Hall, MD, Laurin Council, MD, Arash Kimyai-Asadi, MD, Leonard H. Goldberg, MD
Publikováno v:
JAAD International, Vol 11, Iss , Pp 193-199 (2023)
Background: Patients with chronic lymphocytic leukemia (CLL) are immunocompromised and have both a higher incidence of and more aggressive skin cancers, often requiring treatment with Mohs micrographic surgery. Objective: Characterize operative expec
Externí odkaz:
https://doaj.org/article/bb9d49623c38489aaec7f6c2bf4bee03
553 Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/b622b3313e8d4199bbf2ffb82815bee8
Autor:
Favour A. Akinjiyan, Renee Morecroft, Jordan Phillipps, Tolulope Adeyelu, Andrew Elliott, Soo J. Park, Omar H. Butt, Alice Y. Zhou, George Ansstas
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10771 (2023)
Skin cancers, including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (SCC), and melanoma, are the most common malignancies in the United States. Loss of DNA repair pathways in the skin plays a significant role in tumorigenesis. In re
Externí odkaz:
https://doaj.org/article/c698e37ae7c84b30bc474c6bd640e402
Autor:
Anna Carrano, Natanael Zarco, Jordan Phillipps, Montserrat Lara-Velazquez, Paola Suarez-Meade, Emily S. Norton, Kaisorn L. Chaichana, Alfredo Quiñones-Hinojosa, Yan W. Asmann, Hugo Guerrero-Cázares
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Glioblastoma (GBM) is the most common and devastating primary cancer of the central nervous system in adults. High grade gliomas are able to modify and respond to the brain microenvironment. When GBM tumors infiltrate the Subventricular zone (SVZ) th
Externí odkaz:
https://doaj.org/article/aebdd3f19de74e6f81f92c2a469975ac
Autor:
Shijia Zhang, Kimberly Tang, Guihong Wan, Nga Nguyen, Chenyue Lu, Pearl Ugwu-Dike, Neel Raval, Jayhyun Seo, Nora A. Alexander, Ruple Jairath, Jordan Phillipps, Bonnie W. Leung, Kathleen Roster, Wenxin Chen, Leyre Zubiri, Genevieve Boland, Steven T. Chen, Hensin Tsao, Shadmehr Demehri, Nicole R. LeBoeuf, Kerry L. Reynolds, Kun-Hsing Yu, Alexander Gusev, Shawn G. Kwatra, Yevgeniy R. Semenov
Publikováno v:
medRxiv
J Am Acad Dermatol
J Am Acad Dermatol
BackgroundCutaneous immune-related adverse events (cirAEs) occur in up to 40% of immune checkpoint inhibitor (ICI) recipients. However, the association of cirAEs with survival remains unclear.ObjectiveTo investigate the association of cirAEs with sur
Publikováno v:
Dermatitis®.
Publikováno v:
Journal of Investigative Dermatology. 142:e43-e49
Autor:
Nga Nguyen, Guihong Wan, Pearl Ugwu-Dike, Nora A. Alexander, Neel Raval, Shijia Zhang, Ruple Jairath, Jordan Phillipps, Bonnie Leung, Katie Roster, Jayhyun Seo, Chenyue Lu, Kimberly Tang, Min Seok Choi, Mia S. DeSimone, Nicholas Theodosakis, Munachimso Amadife, Nevada Cox, Thomas K. Le, Feng Liu, Wenxin Chen, Xue Bai, Genevieve Boland, David Liu, Marc S. Hurlbert, Nicole LeBoeuf, Kerry L. Reynolds, Kun-Hsing Yu, Hensin Tsao, Maryam Asgari, Alexander Gusev, Shawn G. Kwatra, Yevgeniy R. Semenov
Publikováno v:
J Am Acad Dermatol
BACKGROUND: Emerging evidence suggests that cutaneous immune-related adverse events (cirAEs) are associated with a survival benefit in the setting of advanced melanoma treated with immune checkpoint inhibitor (ICI) therapy. Previous studies have not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cd559ec79a856bf366d976225bac2f
https://europepmc.org/articles/PMC10260279/
https://europepmc.org/articles/PMC10260279/